datma
datma is a private healthcare technology company that operates a federated real-world data platform connecting health systems, molecular labs, and pharmaceutical companies through privacy-preserving multimodal data collaboration, anchored by datma.FED, datma.BASE, and datma.360.
- Company typePrivate
- Founded2016
- HeadquartersBeaverton, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What datma does
datma is a private Beaverton, Oregon-based healthcare data technology company (founded 2016, formerly Omics Data Automation) that operates a federated real-world data platform enabling health systems, molecular laboratories, and pharmaceutical companies to collaborate on multimodal healthcare data without moving identifiable patient information outside custodian infrastructure. Its product suite centers on datma.FED, a two-sided marketplace launched October 2024 that matches data custodians with pharma data consumers under a shared-upside revenue model; datma.BASE, a data management layer with specialized columnar stores for omics (OmicsDS), imaging (ImageDS/PathDS), and EHR data (EhrDS) connected via FHIR, DICOM, and VCF integrations; and datma.360, a visualization and clinical decision support layer that consolidates omics, clinical, and imaging data into single patient profiles with built-in trial matching, tumor board scheduling, and prior authorization automation.
The platform supports multimodal AI workloads across its data assets: federated causal modeling (datma.WHY), computer vision for digital pathology (used by UPenn researchers to predict heart transplant rejection), NLP over clinical notes and reports, generative AI for patient journey mapping in NSCLC, and knowledge retrieval against OncoKB and ClinicalTrials.gov. The federated network had surpassed 1 million patient lives with multi-omic and pathology coverage as of March 2025, anchored by relationships with Providence Cancer Institute, UCSF Hope Consortium, UPenn, a multi-state hospital network, Novartis, the Broad Institute, UCLA, and the GOAL Consortium. datma also holds US Patent 12,094,105 B2 on automated pathology image labeling, co-developed with Providence Health & Services.
datma monetizes through three streams: marketplace commissions and shared-upside economics on datma.FED, enterprise subscriptions for datma.BASE and datma.360, and professional services for evidence-generation studies that connect pharma sponsors with health system investigators. Distribution is a hybrid of direct enterprise sales and a product-led free tier via the Federated Biomarker Explorer, which lets pharma teams assess biomarker coverage across the network before committing to procurement. The company is privately held, has 11-50 employees, and has raised approximately $21.2M in disclosed funding led by Transformation Capital and Generator Ventures, with no disclosed round since June 2022.
datma firmographics
Firmographics- Name
- datma
- Legal name
- datma, Inc.
- Website
- https://datma.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- datma is a private healthcare technology company that operates a federated real-world data platform connecting health systems, molecular labs, and pharmaceutical companies through privacy-preserving multimodal data collaboration, anchored by datma.FED, datma.BASE, and datma.360.
- Ownership category
- akta.pro rank
datma industry classification
Industry- Product category
- Healthcare Real-World Data / Federated Data Platform
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210), Computer Systems Design and Related Services (54151)
- SIC
- Services-Computer Processing & Data Preparation (7374), Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Real-World Data (RWD) Platforms & Clinical Data Curation (HLACAIAJ)
- akta.pro secondary industries
- Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement) (HLACAIAL), Healthcare Data Lakes, Lakehouses & Cloud Warehouses (HLACAIAA), FHIR/HL7 Data Repositories & Canonical Data Models (HLACAIAI), Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM), De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK)
Keywords
Where datma is headquartered
LocationHeadquarters
- HQ city
- Beaverton
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
datma business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Revenue model
- Data Marketplace Commission: datma.FED operates as a two-sided marketplace where data custodians (health systems, labs) provide data to pharmaceutical companies and research organizations. Revenue is generated through a 'shared-upside' model where custodians earn revenue each time a new data consumer joins the network, and revenue scales as the network expands.
- Platform Subscription/Licensing: datma.BASE and datma.360 are offered as subscription-based platforms for health systems and labs to manage, harmonize, and visualize their healthcare data. Organizations pay for access to data management, integration, and visualization capabilities.
- Evidence Generation Studies: datma facilitates sponsored research collaborations between health systems and pharmaceutical companies, managing study setup, approvals, investigator onboarding, and data execution. Health systems receive funding from pharmaceutical partners for participating in evidence generation projects.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free tier with limited biomarker exploration capabilities |
| Subscription | Annual | Enterprise/paid tier for full datma.FED access |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
datma product offering
Product offeringCore offering
datma develops a cloud-based federated real-world data platform for ingesting, harmonizing, analyzing, and federating large multimodal healthcare datasets including omics, digital pathology, imaging, and EHR data. Its flagship datma.FED acts as a two-sided privacy-preserving marketplace that connects health systems and molecular/reference labs (as data custodians) with pharmaceutical companies and research organizations (as data consumers), enabling federated queries and analytics while keeping identifiable patient data inside the custodian's infrastructure. Supporting products include datma.BASE for data management and harmonization, datma.360 for visualization and clinical decision support, the Federated Biomarker Explorer for free biomarker coverage assessment, and datma.WHY for federated causal modeling.
Product overview
datma offers a platform technology and associated software for ingesting, aggregating, harmonizing, and visualizing heterogeneous multimodal healthcare data. The product architecture consists of a core data management platform (datma.BASE) with specialized data stores (OmicsDS, ImageDS/PathDS, EhrDS), augmented by visualization and clinical decision support tools (datma.360), and a federated data marketplace (datma.FED) that enables secure collaboration without centralizing sensitive data. Additional modules include the Federated Biomarker Explorer for data feasibility assessment and the datma.WHY causal modeling framework.
Differentiator
Problem solved
Functional benefit
Brands
- datma.BASE: A scalable data management platform that provides a solution for ingesting, aggregating, and harmonizing multimodal healthcare data, eliminating data silos and facilitating efficient analysis.
- datma.360
- datma.FED
- Federated Biomarker Explorer
Products and services
- datma.FED A federated real-world data marketplace that connects health systems and molecular/reference labs with pharmaceutical companies and researchers through a secure, privacy-preserving federated model. Enables federated queries and analyses over multimodal data (omics, pathology, imaging, EHR) while identifiable patient-level data never leaves the custodian's infrastructure; offers shared-upside revenue to data custodians and is offered via subscription and a free Federated Biomarker Explorer entry point.
- datma.BASE A scalable biomedical information management platform providing ingestion, aggregation, harmonization, and storage of multimodal healthcare data via proprietary columnar data stores (OmicsDS, ImageDS/PathDS, EhrDS) and a RESTful API with native FHIR, DICOM, and VCF support and JupyterLab integration. Sold to health systems, research institutions, and pharmaceutical customers who need to manage and harmonize their own multimodal data.
- datma.360 An advanced visualization platform that augments EHR systems by consolidating omics, clinical, and imaging data into single comprehensive patient profiles, with clinical trial matching against ClinicalTrials.gov and OncoKB, tumor board scheduling with Microsoft Teams integration, prior authorization automation, cohort discovery, and outcome tracking.
- Federated Biomarker Explorer A free self-serve tool for pharmaceutical teams that checks biomarker coverage and prevalence across datma's federated real-world data network without procurement, IT, or contracts, with a separate health systems variant that provides visibility into data demand without data sharing.
Quantifiable outcome
- Achieved up to 50 providers attending biweekly synchronous tumor board sessions across geographic areas including underserved and remote regions
- +3 more outcomes
Companies that use datma
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
datma technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability11 records
Feature9 records
datma partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core, strategic and minor.
- Rhythm BiosciencescoreExploratory collaboration to evaluate how datma.FED could support Rhythm's cancer risk prediction technology development. Aims to assess contribution of longitudinal, de-identified clinical data to support clinical utility and health economic modelling of Rhythm's geneType™ risk assessment portfolio, potentially enhancing commercialization and clinical validation of genomic-integrated cancer diagnostics.
- GOAL Consortiumcoredatma joined GOAL Consortium as Key Industry Supporter to advance innovation in academic genomics and precision medicine. The consortium represents academic genomics institutions working collaboratively on precision medicine research.
- Providence Health & ServicescoreCollaborative development of patent-protected pathology data labeling system (US12094105B2). Providence is a not-for-profit health system serving the Western U.S. datma's technology was developed in partnership with Providence to address critical challenges in healthcare data sharing.
- NovartisstrategicPharmaceutical collaboration listed under industry partnerships on pharma solutions page, indicating data collaboration for evidence generation and research purposes.
- The Broad InstitutestrategicAcademic research institution partnership listed as industry collaborator for advancing genomic research and precision medicine through federated data analysis.
- UCLAstrategicAcademic partnership for research collaboration in precision medicine and genomic data analysis through federated infrastructure.
- Children's Cancer TherapyminorPediatric oncology research collaboration partner supporting childhood cancer research through federated data analysis capabilities.
- Providence HealthstrategicHealth system partnership for federated data collaboration supporting evidence generation and clinical research initiatives.
- UCSF Hope ConsortiumstrategicResearch collaboration with UCSF's Hope Consortium supporting studies on causes of premature birth using datma.BASE platform for managing multimodal data including surveys, social determinants, Fitbits, clinical charts, and biospecimen analyses.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
datma competitors and assessment
Company assessmentBroad incumbents
- IQVIA: Largest global provider of real-world data, advanced analytics, and technology solutions for life sciences. A dominant incumbent with which datma competes for pharma RWD budgets.
- Flatiron Health: Oncology-focused real-world data and EHR company (Roche subsidiary) serving biopharma and providers. A direct competitor in oncology RWD with substantially larger datasets and pharma relationships.
- Tempus: Multi-modal health data platform combining omics, imaging, and clinical data with AI applications, serving pharma, providers, and patients. A larger, well-capitalized incumbent with overlapping multimodal data capabilities.
- Health Catalyst: Healthcare data and analytics platform serving health systems with data warehousing, integration, and population health. Overlapping platform technology for healthcare data management at scale.
- Palantir Technologies: Data integration and analytics platform with growing healthcare and life sciences presence (e.g., Foundry for biomedicine). Provides competing data infrastructure for pharma and provider organizations.
Direct peers
- TriNetX: Operates a global federated health research network connecting healthcare organizations with biopharma for clinical research and real-world evidence, the most direct analogue to datma.FED's marketplace model.
- ConcertAI: Real-world evidence and AI solutions for oncology and life sciences, operating a federated RWD network serving pharma research. Highly comparable business model and target customer base.
- Syapse: Real-world evidence platform for oncology connecting health systems with life sciences companies. Comparable two-sided RWD business model with focus on precision medicine.
- Lifebit: Federated genomics and biomedical data platform enabling secure, cloud-based analysis across distributed datasets. Direct peer in the federated biomedical data space with comparable technology approach.
Emerging players
- BC Platforms: Genomic and clinical data management platform operating a federated data network for pharma research and precision medicine. Comparable in scope though smaller in scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
datma social profiles
Digital presencedatma compliance and trust
Trust signalCompliance3 records
datma financial estimates
Financial estimateRevenue estimate
Valuation estimate
datma leadership team
Management profileNumber of profiles
Profiles8 records
datma funding detail
Funding detailFunding overview
Funding rounds9 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
datma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about datma
What does datma do?
datma develops a cloud-based federated real-world data platform for ingesting, harmonizing, analyzing, and federating large multimodal healthcare datasets including omics, digital pathology, imaging, and EHR data. Its flagship datma.FED acts as a two-sided privacy-preserving marketplace that connects health systems and molecular/reference labs (as data custodians) with pharmaceutical companies and research organizations (as data consumers), enabling federated queries and analytics while keeping identifiable patient data inside the custodian's infrastructure. Supporting products include datma.BASE for data management and harmonization, datma.360 for visualization and clinical decision support, the Federated Biomarker Explorer for free biomarker coverage assessment, and datma.WHY for federated causal modeling.
Is datma a public or private company?
datma is a private company. It is classified as venture growth investor backed and is currently operating.
When was datma founded?
datma was founded in 2016. It employs 11 to 50 people.
Where is datma based?
datma is headquartered in Beaverton, United States, in the North America region.
How does datma make money?
Three revenue lines are on record. Data Marketplace Commission is the primary driver. The others are platform Subscription/Licensing and evidence Generation Studies.
Who are datma's main competitors?
Broad incumbents on record are IQVIA, Flatiron Health, Tempus, Health Catalyst and Palantir Technologies. Direct peers are TriNetX, ConcertAI, Syapse and Lifebit. BC Platforms is listed as an emerging player.
Does datma have an API?
Yes. datma.BASE provides a RESTful API layer that provides access to data ingestion, extraction and compute. The API enables programmatic access to OmicsDS (genomics, transcriptomics, copy number variation, methylation data), ImageDS (pathology and medical imaging), and EhrDS (EHR/clinical data). APIs support REST endpoints for data ingestion in JSON, YAML, VCF, and other customizable formats. JupyterLab integration allows programmatic interaction. datma.FED provides API access for federated query execution across the network. Cohort specifications and analysis pipelines can be exchanged via API for federated analysis.
What industry is datma in?
datma's product category is Healthcare Real-World Data / Federated Data Platform. Its primary akta.pro industry code is HLACAIAJ, Real-World Data (RWD) Platforms & Clinical Data Curation, with a secondary code of HLACAIAL, Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement). Its NAICS code is 51821 and its SIC code is 7374.